Yara International Crecimiento futuro
Future controles de criterios 2/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Yara International de 16.1% y 2.1% por año respectivamente. Se prevé que el BPA crezca en un 16.1% al año. Se espera que la rentabilidad financiera sea de 5.3% en 3 años.
Información clave
16.1%
Tasa de crecimiento de los beneficios
16.1%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Chemicals | 27.0% |
Tasa de crecimiento de los ingresos | 2.1% |
Rentabilidad financiera futura | 5.3% |
Cobertura de analistas | Good |
Última actualización | 22 Nov 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
What You Can Learn From Yara International ASA's (OB:YAR) P/E
Oct 05Does Yara International (OB:YAR) Have A Healthy Balance Sheet?
Sep 17Is Yara International ASA (OB:YAR) Trading At A 29% Discount?
Aug 30Why Investors Shouldn't Be Surprised By Yara International ASA's (OB:YAR) Low P/S
Jul 03Yara International (OB:YAR) Has A Somewhat Strained Balance Sheet
Jun 12We Discuss Why Yara International ASA's (OB:YAR) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
May 22An Intrinsic Calculation For Yara International ASA (OB:YAR) Suggests It's 49% Undervalued
May 04Revenues Working Against Yara International ASA's (OB:YAR) Share Price
Mar 07Some May Be Optimistic About Yara International's (OB:YAR) Earnings
Feb 17Does Yara International (OB:YAR) Have A Healthy Balance Sheet?
Jan 23Estimating The Intrinsic Value Of Yara International ASA (OB:YAR)
Dec 17Is Yara International (OB:YAR) Using Too Much Debt?
Oct 24An Intrinsic Calculation For Yara International ASA (OB:YAR) Suggests It's 35% Undervalued
Sep 18Downgrade: Here's How Analysts See Yara International ASA (OB:YAR) Performing In The Near Term
Jul 20Do Yara International's (OB:YAR) Earnings Warrant Your Attention?
Jul 07Yara International (OB:YAR) Seems To Use Debt Quite Sensibly
Jun 22Yara International ASA's (OB:YAR) Intrinsic Value Is Potentially 36% Above Its Share Price
Jun 02If EPS Growth Is Important To You, Yara International (OB:YAR) Presents An Opportunity
Apr 02Are Investors Undervaluing Yara International ASA (OB:YAR) By 27%?
Mar 01Is Yara International (OB:YAR) Using Too Much Debt?
Feb 14Here's Why Yara International (OB:YAR) Has Caught The Eye Of Investors
Dec 19An Intrinsic Calculation For Yara International ASA (OB:YAR) Suggests It's 34% Undervalued
Nov 21Yara International (OB:YAR) Seems To Use Debt Quite Sensibly
Oct 09Does Yara International (OB:YAR) Deserve A Spot On Your Watchlist?
Aug 18Are Investors Undervaluing Yara International ASA (OB:YAR) By 49%?
Jun 29Yara International (OB:YAR) Has A Pretty Healthy Balance Sheet
Jun 01With EPS Growth And More, Yara International (OB:YAR) Is Interesting
May 18Yara International (OB:YAR) Is Paying Out A Larger Dividend Than Last Year
May 05Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 14,533 | 730 | 528 | 1,709 | 12 |
12/31/2025 | 14,576 | 698 | 524 | 1,700 | 15 |
12/31/2024 | 14,096 | 398 | 670 | 1,708 | 15 |
9/30/2024 | 13,910 | 548 | 167 | 1,284 | N/A |
6/30/2024 | 14,154 | 263 | 843 | 1,988 | N/A |
3/31/2024 | 14,590 | -38 | 703 | 1,843 | N/A |
12/31/2023 | 15,431 | 48 | 1,149 | 2,288 | N/A |
9/30/2023 | 17,426 | 573 | 2,139 | 3,207 | N/A |
6/30/2023 | 19,703 | 973 | 1,277 | 2,295 | N/A |
3/31/2023 | 22,133 | 1,937 | 1,579 | 2,579 | N/A |
12/31/2022 | 23,902 | 2,777 | 1,465 | 2,391 | N/A |
9/30/2022 | 23,551 | 2,048 | 335 | 1,261 | N/A |
6/30/2022 | 21,898 | 1,506 | 183 | 1,068 | N/A |
3/31/2022 | 19,412 | 1,380 | 364 | 1,163 | N/A |
12/31/2021 | 16,616 | 449 | 597 | 1,406 | N/A |
9/30/2021 | 14,442 | 655 | 1,172 | 1,983 | N/A |
6/30/2021 | 12,932 | 1,136 | 1,985 | 2,733 | N/A |
3/31/2021 | 11,890 | 821 | 1,669 | 2,413 | N/A |
12/31/2020 | 11,591 | 691 | 1,291 | 2,047 | N/A |
9/30/2020 | 11,684 | 645 | 1,467 | 2,275 | N/A |
6/30/2020 | 12,176 | 379 | 963 | 1,901 | N/A |
3/31/2020 | 12,699 | 386 | 797 | 1,845 | N/A |
12/31/2019 | 12,858 | 599 | 811 | 1,907 | N/A |
9/30/2019 | 13,254 | 556 | -16 | 1,129 | N/A |
6/30/2019 | 13,281 | 581 | -247 | 933 | N/A |
3/31/2019 | 13,081 | 139 | -503 | 776 | N/A |
12/31/2018 | 12,928 | 159 | -580 | 756 | N/A |
9/30/2018 | 12,439 | 106 | -430 | 886 | N/A |
6/30/2018 | 11,941 | 98 | N/A | 1,122 | N/A |
3/31/2018 | 11,501 | 392 | N/A | 911 | N/A |
12/31/2017 | 11,358 | 477 | N/A | 791 | N/A |
9/30/2017 | 11,230 | 331 | N/A | 1,033 | N/A |
6/30/2017 | 10,936 | 341 | N/A | 926 | N/A |
3/31/2017 | 10,892 | 616 | N/A | 1,107 | N/A |
12/31/2016 | 11,029 | 736 | N/A | 1,631 | N/A |
9/30/2016 | 12,328 | 891 | N/A | 1,617 | N/A |
6/30/2016 | 12,162 | 1,231 | N/A | 1,839 | N/A |
3/31/2016 | 12,736 | 1,229 | N/A | 1,789 | N/A |
12/31/2015 | 12,203 | 913 | N/A | 1,653 | N/A |
9/30/2015 | 12,740 | 1,114 | N/A | 1,781 | N/A |
6/30/2015 | 13,418 | 916 | N/A | 1,493 | N/A |
3/31/2015 | 12,566 | 817 | N/A | 1,443 | N/A |
12/31/2014 | 12,744 | 1,019 | N/A | 1,150 | N/A |
9/30/2014 | 13,950 | 907 | N/A | 1,391 | N/A |
6/30/2014 | 14,028 | 928 | N/A | 1,944 | N/A |
3/31/2014 | 14,339 | 881 | N/A | 1,782 | N/A |
12/31/2013 | 13,960 | 948 | N/A | 2,025 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (16.1% al año) de YAR es superior a la tasa de ahorro (2.4%).
Beneficios vs. Mercado: Se prevé que los beneficios (16.1% al año) de YAR crezcan más rápidamente que el mercado Norwegian (9.2% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de YAR crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (2.1% al año) de YAR crezcan más despacio que el mercado de Norwegian (2.2% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 2.1% al año) de YAR crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de YAR sea baja dentro de 3 años (5.3%).